Doctors and healthcare professionals in the field of sexual health from across the Middle East will gather in Dubai next week to discuss new clinical findings and research.
International speakers from the US, UK, Germany, Australia, as well as a few from within the region, will share their perspectives on the contemporary practice of sexual medicine, sharing practical data but also insight into available therapy options.
Issues under discussion at the conference include the use of drug therapy in the treatment of male sexual dysfunction; lessons from the female perspective; and the impact of the metabolic syndrome on human sexuality.
“The Middle East medical community is fortunate to be able to host such a high-level, scientific event in Dubai. This event will introduce healthcare providers to the many diverse perspectives of contemporary sexual medicine,” said Dr. Tarek Anis, President of the Pan-Arab Society for Sexual Medicine.
Pfizer, makers of leading medication, Viagra, will act as sole platinum sponsors of the event.
Viagra leads the ED market worldwide, as well as in the Middle East region. More than 27 million men worldwide have been prescribed Viagra, with over 1.5 billion tablets dispensed. Use among men in the Middle East has increased significantly in the past four years after the establishment of Viagra as a solution for enhancing erectile function with an unsurpassed efficacy and safety record.
